建议治疗的自我管理辅助 (SMART) IBD应用程序IBD青少年的随机对照试验:设计和方法
Caroline M Roberts1, Jill M Plevinsky2, Kaitlyn L Gamwell3
1Cincinnati Children's Hospital Medical Center, Center for Health Technology Research, Division of Behavioral Medicine and Clinical Psychology, USA.
Health care transitions
|December 23, 2024
概括
这项研究测试了针对患有炎性肠病 (IBD) 的青少年的移动健康应用程序. 该应用程序提高了自我管理技能,为年轻人提供了医疗保健障碍的可扩展解决方案.
科学领域:
- 青少年健康 青少年健康
- 数字健康干预措施 数字健康干预措施
- 慢性疾病管理 慢性疾病管理
背景情况:
- 青少年遵守医疗方案对于长期健康结果至关重要.
- 资源有限阻碍了青少年获得有效的行为自我管理干预措施.
- 需要进行移动健康干预,以克服医疗保健障碍并改善青少年的护理.
研究的目的:
- 描述推治疗自我管理辅助 (SMART) IBD App随机对照试验的设计和方法.
- 测试SMART IBD应用程序的初步疗效,与小儿炎性肠病 (IBD) 的常规护理相比.
主要方法:
- 一个随机控制的试验试验,涉及30名年龄在13-17岁的IBD患者.
- 参与者被随机分配到SMART IBD应用程序干预组或常规护理组.
- 干预小组使用了应用程序四周,参与每周的自我管理挑战. 两组都完成了基线和治疗后的评估以及每日日记.
主要成果:
- 假设:使用SMART IBD应用程序的参与者将与通常的护理组相比显示显著的自我管理改进.
- 这项研究旨在提供初步证据,证明移动健康应用在青少年自我管理中的有效性.
- 这些发现可以减少医疗保健障碍和资源压力,应用程序是青少年首选的传播方法.
结论:
- 移动健康应用程序显示出支持青少年自我管理IBD等慢性疾病的希望.
- 智能IBD应用程序干预可能提供一种可扩展和可访问的方法来改善青少年的健康结果.
- 进一步的研究可以验证这些发现,并探索mHealth在儿科医疗保健中的更广泛应用.
相关概念视频
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
315
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
315
01:30Irritable Bowel Syndrome III: Medical and Nursing Management
166
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
166
01:29Inflammatory Bowel Disease IV: Pharmacological Management
111
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
111
01:21Inflammatory Bowel Disease V: Surgical Management
116
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
116
01:17Drugs for Treatment of Diarrhea-Predominant IBS
147
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
147
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
141
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
141